Vaccine adjuvants for infectious disease in the clinic
Adjuvants, materials added to vaccines to enhance the resulting immune response, are
important components of vaccination that are many times overlooked. While vaccines …
important components of vaccination that are many times overlooked. While vaccines …
Safety and immunogenicity of betuvax-CoV-2, an RBD-Fc-based SARS-CoV-2 recombinant vaccine: preliminary results of the first-in-human, randomized, double …
AV Kudriavtsev, AV Vakhrusheva, NA Kryuchkov… - Vaccines, 2023 - mdpi.com
COVID-19, being a life-threatening infection that evolves rapidly, remains a major public
health concern calling for the development of vaccines with broad protection against …
health concern calling for the development of vaccines with broad protection against …
Vaccine adjuvants for infectious disease in the clinic
G Morgan, N Thotathil, Z Zhao… - Bioengineering & …, 2024 - search.proquest.com
Adjuvants, materials added to vaccines to enhance the resulting immune response, are
important components of vaccination that are many times overlooked. While vaccines …
important components of vaccination that are many times overlooked. While vaccines …
Rapid and Scalable Production of Functional SARS-CoV-2 Virus-like Particles (VLPs) by a Stable HEK293 Cell Pool
S Puarattana-aroonkorn, K Tharakaraman… - Vaccines, 2024 - mdpi.com
At times of pandemics, such as the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection, the situation demands rapid development and production timelines of safe …
CoV-2) infection, the situation demands rapid development and production timelines of safe …
[HTML][HTML] Comparative Analysis of the Neutralizing Capacity of Monovalent and Bivalent Formulations of Betuvax-CoV-2, a Subunit Recombinant COVID-19 Vaccine …
AV Vakhrusheva, EA Romanovskaya-Romanko… - Vaccines, 2024 - pmc.ncbi.nlm.nih.gov
SARS-CoV-2, the causal agent of the COVID-19 pandemic, is characterized by rapid
evolution, which poses a significant public health challenge. Effective vaccines that provide …
evolution, which poses a significant public health challenge. Effective vaccines that provide …
ВАКЦИНА НОВОГО ПОКОЛЕНИЯ НА ОСНОВЕ ВИРУСОПОДОБНЫХ ЧАСТИЦ «БЕТУВАКС-КоВ-2» ПРОТИВ COVID-19
АВ Вахрушева, АВ Кудрявцев, НА Крючков… - IX Международная …, 2022 - elibrary.ru
Субъединичная вакцина «Бетувакс-КоВ-2», направленная против SARS-CoV-2,
основана на технологии вирусоподобных сферических наночастиц «Бетусфера» с …
основана на технологии вирусоподобных сферических наночастиц «Бетусфера» с …